UNSPSC 51273813: Camphor/eucalyptus oil/menthol/methyl salicylate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE650. This VA Drug Class (DE650) classifies this compound as belonging to the group ANALGESICS, TOPICAL.

UNSPSC 51273813 Camphor/eucalyptus oil/menthol/methyl salicylate is a Commodity code that, based on recent state and local procurement activity, shows limited or no direct sourcing of the nominal chemical ingredients. The single recent opportunity tagged to this code—Seminole County, Florida's IFB 60459723LAS—solicits naloxone and drug deactivation systems for community health initiatives, a product category unrelated to the code's stated scope. State and local governments do source camphor, eucalyptus oil, menthol, and methyl salicylate through various channels, including pharmaceutical and health-care product procurement, topical pain-relief formulations, industrial cleaning supplies, and veterinary or agricultural applications; however, the recent opportunity record does not reflect current buying patterns under this code.

Seminole County posted IFB 60459723LAS on June 30, 2026, with a response deadline of July 26, 2023 (note the date inconsistency in the source), requiring 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Bidders must submit proposals electronically through the county's e-Procurement Portal, include all shipping and delivery costs, provide unit pricing for each line item, and comply with E-Verify requirements and drug-free workplace certification. The initial contract term is two years with an optional one-year renewal and a three-month probationary period. The source indicates potential FEMA funding with associated federal compliance requirements. The code record provides insufficient recent activity to characterize issuing-body mix, geographic concentration, or market conditions; business development professionals should verify whether naloxone and deactivation systems represent a systematic retag or an isolated data quality issue before allocating resources to this code.